99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer

European Journal of Surgical Oncology

Volumn 33, Issue 7, 2007, Pages 902-906

  Rubello, D ^a   Salvatori, M ^b   Casara, D ^c   Piotto, A ^d   Toniato, A ^d   Gross, M D ^e   Al Nahhas, A ^f   Muzzio, P C ^c   Pelizzo, M R ^d  

^a S Maria della Misericordia Rovigo Hospital   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

131I negative recurrence; 99mTc sestamibi positive recurrence; Radio guided surgery; Recurrent disease; Thyroid cancer

Indexed keywords

IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROGLOBULIN; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOSURGERY; RECURRENT CANCER; STATISTICAL SIGNIFICANCE; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROID SURGERY; TUMOR VOLUME; WHOLE BODY SCINTISCANNING; METABOLISM; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 34548107302     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.12.016     Document Type: Article

References (31)

1. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 1-33
2. Schlumberger M., and Pacini F. Thyroid tumors (2003), Editions Nucleon, Paris
3. Mazzaferri E.L., and Kloos R.T. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86 (2001) 1447-1463
4. 131I scan. Thyroid Clin Exp 9 (1997) 95-100
5. 131I whole body scintigraphy: importance of 99mTc-MIBI scan combined with high resolution neck ultrasonography. Tumori 85 (1998) 120-125
6. Rubello D., Saladini G., Carpi A., and Casara D. Nuclear medicine imaging procedures in differentiated thyroid carcinoma patients with negative iodine scan. Biomed Pharmacother 54 (2000) 337-344
7. 131I in the detection of differentiated thyroid cancer metastases. Nucl Med Commun 21 (2000) 917-923
8. Alam M.S., Kasagi K., Misaki T., et al. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation. Thyroid 8 (1998) 1091-1100
9. Mansberg R., Crawford B., Uren R.F., and Thompson J.F. Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123. Clin Nucl Med 30 (2005) 43
10. Wu H.-S., Liu F.-Y., Huang W.-S., Liu Y.-C., Chang C.-T., and Kao C.-H. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan. Clin Radiol 58 (2003) 787-790
11. Chen Y.-K., Liu F.-Y., Yen R.-F., and Kao C.-H. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma. Acad Radiol 10 (2003) 835-839
12. Hurtado-Lopez L.M., Arellano-Montano S., Torres-Acosta E.M., et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 31 (2004) 1273-1279
13. Fujie S., Okumura Y., Sato S., et al. Diagnostic capabilities of I-131, Tl-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy. Acta Med Okayama 59 (2005) 99-107
14. Dietlein M., Moka D., Scheidhauer K., et al. Follow-up of differentiated thyroid cancer; comparison of multiple diagnostic tests. Nucl Med Commun 21 (2000) 991-1000
15. Hsu C., Liu F., Yen R., and Kao C. Tc-99m MIBI SPECT in detecting metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan. Endocr Res 29 (2003) 9-15
16. Rubello D., Mazzarotto R., and Casara D. The role of technetium 99m methoxyisobutyl isonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 27 (1999) 431-440
17. 99mTc-sestamibi. (editorial). Nucl Med Commun 27 (2005) 1-4
18. 99mTc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure and preliminary results. Eur J Nucl Med 29 (2002) 1201-1205
19. Rubello D., Pelizzo M.R., Casara D., et al. Radio-guided surgery for non-(131)I-avid thyroid cancer. Thyroid 16 (2006) 1105-1111
20. Casara D., Rubello D., Saldini G., De Besi P., Fassina A., and Busnardo B. Differentiated thyroid carcinoma in the elderly. Thyroid Clin Exp 4 (1992) 333-339
21. Girelli M., Busnardo B., Amerio R., Nacamulli D., Casara D., and Pelizzo M. Serum thyroglobulin levels in patients with well-differentiated thyroid cancer during suppressive therapy: study on 429 patients. Eur J Nucl Med 10 (1985) 252-256
22. 99mTc-MIBI for recurrent and metastatic differentiated thyroid carcinoma. Nuckearmedizin 37 (1997) 7-12
23. Franceschi M., Kusic Z., Fransceschi D., Luiniac L., and Roncevic S. Thyroglobulin determination, neck ultrasonography and iodine-131 whole body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37 (1996) 446-451
24. Boz A., Arici C., Güngör F., Yildiz A., Colak T., and Karayalcin B. Gamma-probe-guided resection and scanning with Tc-99m MIBI of a local recurrence of follicular thyroid carcinoma. Clin Nucl Med 26 (2001) 820-822
25. Sarikaya A., Huseyinova G., Irfanoglu M.E., Erkmen N., Cermik T.F., and Berkarada S. The relationship between 99Tcm-sestamibi uptake and ultrastructural cell types of thyroid tumors. Nucl Med Commun 22 (2001) 39-44
26. Songdale J., Younes A., Maublant J., Veyre A., Platts E.A., and Pickett R.D. Uptake of Tc-99m-tetrafosmin in isolated mitochondria: evidence for an active mechanism. J Nucl Med 35 (1994) 46P-47P
27. 99mTc-MIBI and ultrasound imaging protocol. Eur J Nucl Med 27 (2000) 1300-1304
28. 99mTc-MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 28 (2001) 1351-1359
29. Meller B., Sahlmann C., Horstmann O., Gerl J., Baehre M., and Meller J. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG. Nuclearmedizin 44 (2005) N23-N25
30. 131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab 83 (1998) 2675-2680
31. Salvatori M., Rufini V., Reale F., et al. Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer. World J Surg 27 (2003) 770-775